Cargando…

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients

BACKGROUND: Efficient monitoring and control of coronavirus disease 2019 (COVID-19) require access to diagnostic tests, and serological diagnostic testing is desirable. In the current study, antibodies were investigated in patients recently diagnosed with severe acute respiratory syndrome coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chansaenroj, Jira, Yorsaeng, Ritthideach, Posuwan, Nawarat, Puenpa, Jiratchaya, Sudhinaraset, Natthinee, Chirathaworn, Chintana, Poovorawan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942515/ https://www.ncbi.nlm.nih.gov/pubmed/33750394 http://dx.doi.org/10.1186/s12985-021-01530-2

Ejemplares similares

Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019
por: Pasittungkul, Siripat, et al.
Publicado: (2021)

Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020
por: Puenpa, Jiratchaya, et al.
Publicado: (2020)

Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2022)

Evolutionary and Genetic Recombination Analyses of Coxsackievirus A6 Variants Associated with Hand, Foot, and Mouth Disease Outbreaks in Thailand between 2019 and 2022
por: Puenpa, Jiratchaya, et al.
Publicado: (2022)

Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020
por: Chirathaworn, Chintana, et al.
Publicado: (2020)

Cytokines and Chemokines in Chikungunya Virus Infection: Protection or Induction of Pathology
por: Chirathaworn, Chintana, et al.
Publicado: (2020)

Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
por: Khongwichit, Sarawut, et al.
Publicado: (2021)

Atypical skin manifestation in severe acute chikungunya infection in a pregnant woman: a case report
por: Benjamanukul, Saovanee, et al.
Publicado: (2022)

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
por: Suntronwong, Nungruthai, et al.
Publicado: (2023)

Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis
por: Benjamanukul, Saovanee, et al.
Publicado: (2021)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
por: Yorsaeng, Ritthideach, et al.
Publicado: (2023)

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

The impact of COVID-19 and control measures on public health in Thailand, 2020
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Large-scale outbreak of Chikungunya virus infection in Thailand, 2018–2019
por: Khongwichit, Sarawut, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
por: Chansaenroj, Jira, et al.
Publicado: (2023)

Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma
por: Pratedrat, Pornpitra, et al.
Publicado: (2023)

Human norovirus GII.4 Hong Kong variant shares common ancestry with GII.4 Osaka and emerged in Thailand in 2016
por: Chuchaona, Watchaporn, et al.
Publicado: (2021)

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
por: Chansaenroj, Jira, et al.
Publicado: (2022)

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

High prevalence of DS-1-like rotavirus infection in Thai adults between 2016 and 2019
por: Chansaenroj, Jira, et al.
Publicado: (2020)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Rapid electrochemical detection of coronavirus SARS-CoV-2
por: Chaibun, Thanyarat, et al.
Publicado: (2021)

Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
por: Chinchai, Teeraporn, et al.
Publicado: (2019)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Phylogenetic molecular evolution and recombination analysis of complete genome of human parechovirus in Thailand
por: Chieochansin, Thaweesak, et al.
Publicado: (2021)

SARS-CoV-2 Transmission from Human to Pet and Suspected Transmission from Pet to Human, Thailand
por: Piewbang, Chutchai, et al.
Publicado: (2022)

Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens
por: Nimsamer, Pattaraporn, et al.
Publicado: (2021)

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
por: Puenpa, Jiratchaya, et al.
Publicado: (2019)

High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation
por: Sintusek, Palittiya, et al.
Publicado: (2018)

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
por: Nilyanimit, Pornjarim, et al.
Publicado: (2017)

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection
por: Poovorawan, Kittiyod, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_886i5l33gjkes1a9gdcgmnd5oa